or

Products

Pain Management

Gastroenterology

Nephrology

Oncology

Consumer Health


Recofol

Product: Recofol® (propofol) injection
Indication:

Induction and maintenance of general anesthesia (Rx)
Sedation during intensive care (Rx)
Sedation during surgical and diagnostic procedures with local anesthesia (Rx)

Status: Marketed

RecofolLicensed from Bayer Schering Pharma, Recofol® was the first of the new class of intravenous anesthetic agents – the alkylphenols – to be commercially introduced in China. It is a sedative-hynoptic agent with rapid onset and recovery, with broad applications in general anesthesia and sedation.

As Recofol® is not an analgesic agent, supplementation with intravenous opioids such as fentanyl or sufentanil is required.

Download Recofol Brochure

Download Recofol Package Insert